
Tzield Efficacy and Safety
Learn more



AD Disease Overview

AD Burden on Patients

Epidemiology
.jpg)


Once diagnosed with stage 3 AT1D, patients require lifelong exogenous insulin. This significantly impacts activities of daily living and quality of life, particularly during childhood and adolescence.1-3
